Interaction of estramustine with tubulin isotypes

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Estramustine is an antimitotic agent used in cancer therapy.
• Microtubules, composed of alpha- and beta-tubulin, are critical for cell division.
• Understanding estramustine's molecular interactions is key to optimizing its efficacy and overcoming resistance.

Purpose of the Study:

• To investigate the binding interactions of estramustine with tubulin.
• To determine the estramustine binding site on tubulin.
• To explore the role of tubulin isotypes in estramustine response and resistance.

Main Methods:

• Photoaffinity labeling with [14C]estramustine.
• Equilibrium dialysis to determine affinity constants.
• Competition assays with vinblastine, rhizoxin, paclitaxel, and colchicine.
• Analysis of tubulin isotype incorporation in bovine and human cells.

Main Results:

• Estramustine directly labels both alpha- and beta-tubulin.
• The binding affinity constant for estramustine-tubulin interaction was determined.
• Estramustine's binding site is distinct from colchicine and vinblastine but may overlap with paclitaxel.
• Reduced [14C]estramustine incorporation into beta III-tubulin was observed, particularly in estramustine-resistant cells.

Conclusions:

• Estramustine binds to tubulin at a site distinct from colchicine and vinblastine.
• The binding site may partially overlap with that of paclitaxel.
• Beta III-tubulin overexpression may contribute to estramustine resistance in human prostate carcinoma.